Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Haematologica|September 18, 2025
Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed/refractory primary mediastinal B-cell lymphomaArmando Santoro, Ciro Maria Improta, Barbara Sarina, et al.
European Journal of Haematology|January 27, 2007
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusionElisabetta Todisco, Luca Castagna, Barbara Sarina, et al.
Life (Basel, Switzerland)|March 27, 2025
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational StudyStefania Bramanti, Daniela Taurino, Filippo Magri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2019
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on OutcomesStefania Bramanti, Valeria Calafiore, Elena Longhi, et al.
Transplantation and Cellular Therapy|March 26, 2023
Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin LymphomaChiara De Philippis, Daniele Mannina, Laura Giordano, et al.
British Journal of Haematology|September 1, 2025
Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysisJacopo Mariotti, Chiara Pinton, Laura Giordano, et al.
Cytotherapy|May 22, 2024
Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohortJacopo Mariotti, Cristina Zucchinetti, Laura Giordano, et al.
Cells|January 22, 2024
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage RegimensJacopo Mariotti, Francesca Ricci, Laura Giordano, et al.
European Journal of Haematology|January 24, 2019
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamideJacopo Mariotti, Chiara De Philippis, Stefania Bramanti, et al.
Medical Physics|December 11, 2013
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapyPietro Mancosu, Piera Navarria, Luca Castagna, et al.
Pageof 7